Crilley PA - Search Results

1

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.

Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, Brodsky I, Martino S, Lazarus HM, Erban JK, Sickles C, Glick JH. Stadtmauer EA, et al. Among authors: crilley pa. N Engl J Med. 2000 Apr 13;342(15):1069-76. doi: 10.1056/NEJM200004133421501. N Engl J Med. 2000. PMID: 10760307 Free article. Clinical Trial.

2

Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.

Schulman KA, Stadtmauer EA, Reed SD, Glick HA, Goldstein LJ, Pines JM, Jackman JA, Suzuki S, Styler MJ, Crilley PA, Klumpp TR, Mangan KF, Glick JH. Schulman KA, et al. Among authors: crilley pa. Bone Marrow Transplant. 2003 Feb;31(3):205-10. doi: 10.1038/sj.bmt.1703795. Bone Marrow Transplant. 2003. PMID: 12621482 Clinical Trial.

3

Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen.

Brodsky R, Topolsky D, Crilley P, Bulova S, Brodsky I. Brodsky R, et al. Am J Clin Oncol. 1990 Jun;13(3):221-5. doi: 10.1097/00000421-199006000-00009. Am J Clin Oncol. 1990. PMID: 2346127

4

The role of busulfan/cyclophosphamide regimens in allogeneic and autologous bone marrow transplantation.

Brodsky I, Bulova S, Crilley P. Brodsky I, et al. Cancer Invest. 1989;7(5):509-13. doi: 10.3109/07357908909041380. Cancer Invest. 1989. PMID: 2620248 No abstract available.

5

Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?

Ener RA, Meglathery SB, Cuhaci B, Topolsky D, Styler MJ, Crilley P, Brodsky I, Kahn SB, King RS. Ener RA, et al. Am J Clin Oncol. 2001 Feb;24(1):19-25. doi: 10.1097/00000421-200102000-00003. Am J Clin Oncol. 2001. PMID: 11232944

6

Peripheral blood stem cell transplant in breast cancer.

Crilley P, Goldstein LJ. Crilley P, et al. Semin Oncol. 1995 Jun;22(3):238-49. Semin Oncol. 1995. PMID: 7777868 Review. No abstract available.

7

High-dose cyclophosphamide without stem-cell rescue for refractory CIDP.

Brannagan TH 3rd, Pradhan A, Heiman-Patterson T, Winkelman AC, Styler MJ, Topolsky DL, Crilley PA, Schwartzman RJ, Brodsky I, Gladstone DE. Brannagan TH 3rd, et al. Among authors: crilley pa. Neurology. 2002 Jun 25;58(12):1856-8. doi: 10.1212/wnl.58.12.1856. Neurology. 2002. PMID: 12084892

8

High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma.

Lazarus HM, Crilley P, Ciobanu N, Creger RJ, Fox RM, Shina DC, Bulova SI, Gucalp R, Cooper BW, Topolsky D, et al. Lazarus HM, et al. J Clin Oncol. 1992 Nov;10(11):1682-9. doi: 10.1200/JCO.1992.10.11.1682. J Clin Oncol. 1992. PMID: 1403051 Clinical Trial.

9

Syngeneic marrow transplantation in multiple myeloma.

Topolsky D, Crilley P, Leasure N, Bulova S, Brodsky I. Topolsky D, et al. Leuk Res. 1992;16(4):415-6. doi: 10.1016/0145-2126(92)90145-w. Leuk Res. 1992. PMID: 1564944

10

Autologous bone marrow transplantation for advanced stage mycosis fungoides.

Bigler RD, Crilley P, Micaily B, Brady LW, Topolsky D, Bulova S, Vonderheid EC, Brodsky I. Bigler RD, et al. Bone Marrow Transplant. 1991 Feb;7(2):133-7. Bone Marrow Transplant. 1991. PMID: 2049557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page